Nanoparticle derivatives of gemcitabine

Details Nanoparticle derivatives of gemcitabine Nanoparticle derivatives of gemcitabine

2010-03-04

2011-10-25

Lewis, Patrick (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S043000, C536S028100

Reexamination Certificate

active

08044034

ABSTRACT:
The use of squalenic acid or a derivative thereof in formulating at least one polar active principle with a molecular weight of 100 Da or more, in the form of nanoparticles, and pharmaceutical compositions thereof.

REFERENCES:
patent: 6384019 (2002-05-01), Sandvold et al.
patent: 6524595 (2003-02-01), Perrier et al.
patent: 2002/0042391 (2002-04-01), Myhren et al.
patent: 0693077 (1996-01-01), None
patent: 9832762 (1998-07-01), None
Ceruti et al., Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as inhibitors of liver and yeast oxidosqualene cyclase J. Chem. Soc., Perkin Trans. 1, 2002, 1477-1488.
Fessi et al., Nanocapsule formation by interfacial polymer deposition following solvent displacement International Journal of Pharmaceutics, 55 (1989) R1-R4.
Heinemann et al., Comparison of the Cellular Pharmacokinetics and Toxicity of 2′,2′-Difluorodeoxycytidine and 1-β-D-Arabinofuranosylcytosine Cancer Research 48, 4024-4031, Jul. 15, 1988.
Heinemann et al., Cellular Elimination of 2′,2′-Difluorodeoxycytidine 5′ -Triphosphate: A Mechanism of Self-Potentiation Cancer Research 52, 533-539, Feb. 1, 1992.
Hertel et al., Evaluation of the Antitumor Activity of Gemcitabine (2′ ,2′ -Difluoro-2′ -deoxycytidine) Cancer Research 50, 4417-4422, Jul. 15, 1990.
Plunkett, et al., Gemcitabine: Metabolism, Mechanisms of Action, and Self-Potentiation Seminars in Oncology vol. 22, No. 4 Suppl II Aug. 1995: pp. 3-10.
Sharma et al., Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma Journal of Chromatography B, 655, (1994) 315-319.
Storniolo et al., Preclinical, Pharmacologic, and Phase I Studies of Gemcitabine Seminars in Oncology vol. 24, No. 2 Suppl 7 Apr. 1997: pp. S7-2-S7-7.
van Tamelen, Bioorganic Chemistry: Sterols and Acyclic Terpene Terminal Epoxides Sterols and Acyclic Terpene Terminal Epoxides Apr. 1968 111-120.
Kaul et al., Pharmaceutical Research (2002), vol. 19, pp. 1061-1067.

Affiliated with

Also associated with

Rating

Nanoparticle derivatives of gemcitabine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticle derivatives of gemcitabine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticle derivatives of gemcitabine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4301523